Related Experiment Video
Updated: Jul 18, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Percutaneous continuous aortic flow augmentation for cardiac recovery in a chronic heart failure patient with
Amir Saberin1, Bettina Mueller, Marvin A Konstam
1Centre Hospitalier de Luxembourg, Luxembourg City, Grand Duchy of Luxembourg.
Abstract:
Peripheral vascular disease is an obstacle to the use of continuous aortic flow augmentation (CAFA). The authors used CAFA in a patient with a 50% stenosis of the left iliac artery. Five hours after initiating therapy, flow rates dropped from 1.47 L/min to 0.2 L/min, possibly due to obstruction around the inflow cannula near the site of the iliac artery stenosis. Flow was stabilized by adequate fluid infusion and successfully restored by slightly withdrawing the tip of the inflow catheter. This finding suggests that peripheral vascular disease is a relative-not an absolute-contraindication for CAFA, but requires close monitoring of flow during CAFA therapy.
Related Concept Videos
Aortic Regurgitation IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease IV: Nursing Management

